Seborrheic dermatitis is one of those afflictions which has plagued mankind since the dawn of recorded history. As common as the common cold, it has just as stubbornly resisted any sort of treatment. During the past 100 years, few, if any new drugs have been offered which were much better than the ancient combination of sulfur and resorcinol, and other similiarly venerable but partially effective combinations.
Myriads of preparations, both proprietary and nonproprietary have been offered on the market for the avowed purpose of at least giving some relief from this most distressing syndrome but with always the same result, only partial beneficial effect.
Accordingly, when Kittleson* announced the discovery of a new class of organic compounds which proved to possess an unusually broad bacterial spectrum and were also exceptionally effective against a considerable number of fungi, it was thought that here was a substance which would
BALL FI. A New Treatment for Seborrheic Dermatitis: A Clinical Investigation. AMA Arch Derm. 1955;71(6):696–698. doi:10.1001/archderm.1955.01540300018005
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: